Clinical trial
Snapshot 3D Ultra-high-resolution OCT and Hyperspectral AF of In-vivo Retina
NCT03963817 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Snapshot 3D Ultra-high-resolution OCT and Hyperspectral AF of In-vivo Retina
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 6, 2023
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age related macular degeneration